Compare Agilent Technologies Inc (A) vs Vanguard Growth Index Fund ETF (VUG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Vanguard Growth Index Fund ETF — how do they compare? Agilent Technologies Inc trades at $128.87 (market cap $37.04B), while Vanguard Growth Index Fund ETF trades at $85.79. The key difference: Agilent Technologies Inc pays a 0.78% dividend while Vanguard Growth Index Fund ETF pays none, and Vanguard Growth Index Fund ETF is trading nearer its 52-week high, Agilent Technologies Inc nearer its low. Which is the better fit depends on your goals.
| A | VUG | |
|---|---|---|
Market Cap | $37.04B | — |
Sector | Health | Sector/Thematic |
52-Week High | $157.20 | $90.29 |
52-Week Low | $110.24 | $70.00 |
Enterprise Value | $38.59B | — |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
VUG trades at $86.68, up 1.38% on the day, with a bullish technical signal from moving averages but bearish oscillators. The ETF recently executed a 1:6 stock split on April 21, 2026, and declared a $0.09 dividend payable June 30, 2026. Support sits near $85–$86, with resistance at $87–$88. Media coverage highlights its low 0.04% expense ratio and strong performance against active funds, though technology concentration at 56% of assets poses sector risk.
Outlook remains positive given cost efficiency and growth exposure, but investors face volatility from tech reliance and market sentiment shifts. The fund's large-cap focus offers stability, yet macroeconomic pressures could challenge returns. Risks include sector rotation and valuation sensitivity, balanced by long-term growth potential in U.S. equities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Vanguard Growth Index Fund ETF
VUG is an index-based ETF that tracks the CRSP US Large Cap Growth Index, providing concentrated exposure to the largest and fastest-growing companies in the United States. It focuses on stocks with high growth potential across tech, communication, and consumer sectors, serving as a low-cost, high-conviction core holding for long-term capital appreciation.
Read more on VUG →
